DEBORAH CHASE: Open Payments
NPI 1447331830 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$432 in 9 payments from 5 companies in 2025. Trend: 2023 $56 · 2024 $104 · 2025 $432
Food & beverage: $432
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $264 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $67 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Amgen Inc. | 1 | $16 |
Products named: Wegovy, Ozempic, Sunosi, XIFAXAN, OTEZLA.
Industry payments across CO — which companies pay providers there.
